Generic Products of Antiepileptic Drugs: A Perspective on Bioequivalence, Bioavailability, and Formulation Switches Using Monte Carlo Simulations

Vangelis Karalis(National and Kapodistrian University of Athens), Meir Bialer(Hebrew University of Jerusalem), Panos Macheras(National and Kapodistrian University of Athens)
CNS Drugs
October 2, 2013
10.1007/s40263-013-0112-8
Cited by 25

Related Papers

Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
|Epilepsy Research|2006|481
Therapeutic Drug Monitoring of the Newer Antiepileptic Drugs
|Therapeutic Drug Monitoring|2003|321
The Integration of Artificial Intelligence into Clinical Practice
|Applied Biosciences|2024|225
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
|The American Journal of Medicine|2021|122
3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications
|Pharmaceutics|2021|78